I encourage everyone to visit EU Clinical Trials Register to search for protocol and information on BetonMace... All details are shown and outlined including primary end points and secondary objectives :)

I'm leaning to 18 month trial as sick patients increases Mace occurrence (sad but true the sick are helping our drug get to market )

Male and Female subjects age 18 and over with documented diagnosed T2DM and a CVD event not "LESS" then 7 days and "No MORE" then 90 days prior to Visit 1 (one or more of the three primary criteria must be satisfied for enrollment )

Good read... go check out trial design

Stock